Association Between the Effectiveness and Immunogenicity of Inactivated SARS-CoV2 Vaccine (CoronaVac) with the Presence of Hypertension among Health Care Workers.
Autor: | Rifai A; Nephrology and Hypertension Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya - Saiful Anwar General Hospital, Malang, Indonesia., Wahono CS; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya - Saiful Anwar General Hospital, Malang, Indonesia., Pratama MZ; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya - Saiful Anwar General Hospital, Malang, Indonesia., Handono K; Department of Clinical Pathology, Faculty of Medicine Universitas Brawijaya - Saiful Anwar General Hospital, Malang, Indonesia., Susianti H; Department of Clinical Pathology, Faculty of Medicine Universitas Brawijaya - Saiful Anwar General Hospital, Malang, Indonesia., Iskandar A; Department of Clinical Pathology, Faculty of Medicine Universitas Brawijaya - Saiful Anwar General Hospital, Malang, Indonesia., Diyah N; Department of Microbiology, Faculty of Medicine Universitas Brawijaya - Saiful Anwar General Hospital, Malang, Indonesia., Santoningsih D; Department of Microbiology, Faculty of Medicine Universitas Brawijaya - Saiful Anwar General Hospital, Malang, Indonesia., Samsu N; Nephrology and Hypertension Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya - Saiful Anwar General Hospital, Malang, Indonesia., Gunawan A; Nephrology and Hypertension Division, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya - Saiful Anwar General Hospital, Malang, Indonesia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2022 Apr 03; Vol. 44 (3), pp. 233-239. Date of Electronic Publication: 2022 Jan 07. |
DOI: | 10.1080/10641963.2021.2022687 |
Abstrakt: | Objective: This study aimed to observe the association between the presence of hypertension with Covid-19 vaccine effectiveness among healthcare workers who received CoronaVac vaccination. Methods: We conducted a prospective cohort study in Saiful Anwar General Hospital, Malang, Indonesia on 155 healthcare workers aged 18-59 years old who already received twice of the CoronaVac (Sinovac Life Science, Beijing, China) injection with 14-day intervals. Hypertension was diagnosed according to the 2020 International Society of Hypertension. Subjects were monitored for six months. The primary outcome was the rate of Covid-19 diagnosed by the pharyngeal swab for the real-time reverse transcription-polymerase chain reaction (RT-PCR) examination. The secondary endpoints were: (1) severity of Covid-19 among infected participants; (2) rate of hospitalizations; and (3) anti-SRBD antibody levels measured by ECLIA. Results: Among 155 participants, 18.7% of them were diagnosed with hypertension, and 31.0% had the desirable BP target according to the current guidelines. Subjects with hypertension, especially those with uncontrolled blood pressure, had a higher incidence of Covid-19 infection than subjects without hypertension. Subjects with symptomatic Covid-19 and hospitalized because of Covid-19 were higher in participants with hypertension. The anti-SRBD antibody levels were lower in the second month after CoronaVac vaccination in hypertensive subjects. In contrast, comparable anti-SRBD levels were seen from both groups at sixth months after vaccination. Conclusion: Hypertension was associated with lower vaccine effectiveness in healthcare workers. Subjects with hypertension had a higher risk of being infected with Covid-19 despite getting a complete dose of vaccination and lower antibody production. |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |